2.91 USD
-0.16 (-5.21%)
We assign a fundamental rating of 3 out of 10 to DWTX. DWTX was compared to 525 industry peers in the Biotechnology industry. No worries on liquidiy or solvency for DWTX as it has an excellent financial health rating, but there are worries on the profitability. DWTX is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- DWTX had negative earnings in the past year.
- In the past year DWTX has reported a negative cash flow from operations.
- DWTX had negative earnings in each of the past 5 years.
- DWTX had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- The Return On Assets of DWTX (-43.46%) is comparable to the rest of the industry.
- Looking at the Return On Equity, with a value of -51.66%, DWTX is in the better half of the industry, outperforming 66.10% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -43.46% | ||
| ROE | -51.66% | ||
| ROIC | N/A |
ROA(3y)-95.71%
ROA(5y)-84.23%
ROE(3y)-108.75%
ROE(5y)-94.18%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for DWTX so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- DWTX has more shares outstanding than it did 1 year ago.
- DWTX has less shares outstanding than it did 5 years ago.
- DWTX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- DWTX has an Altman-Z score of 1.14. This is a bad value and indicates that DWTX is not financially healthy and even has some risk of bankruptcy.
- DWTX has a Altman-Z score of 1.14. This is in the better half of the industry: DWTX outperforms 64.00% of its industry peers.
- There is no outstanding debt for DWTX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.14 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- A Current Ratio of 4.49 indicates that DWTX has no problem at all paying its short term obligations.
- The Current ratio of DWTX (4.49) is comparable to the rest of the industry.
- DWTX has a Quick Ratio of 4.49. This indicates that DWTX is financially healthy and has no problem in meeting its short term obligations.
- DWTX's Quick ratio of 4.49 is in line compared to the rest of the industry. DWTX outperforms 53.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.49 | ||
| Quick Ratio | 4.49 |
3. Growth
3.1 Past
- DWTX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -209.16%.
EPS 1Y (TTM)-209.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- The Earnings Per Share is expected to grow by 17.79% on average over the next years. This is quite good.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-58.18%
EPS Next 2Y26.51%
EPS Next 3Y17.79%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- DWTX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year DWTX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- DWTX's earnings are expected to grow with 17.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.51%
EPS Next 3Y17.79%
5. Dividend
5.1 Amount
- No dividends for DWTX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
DOGWOOD THERAPEUTICS INC / DWTX FAQ
What is the ChartMill fundamental rating of DOGWOOD THERAPEUTICS INC (DWTX) stock?
ChartMill assigns a fundamental rating of 3 / 10 to DWTX.
What is the valuation status of DOGWOOD THERAPEUTICS INC (DWTX) stock?
ChartMill assigns a valuation rating of 0 / 10 to DOGWOOD THERAPEUTICS INC (DWTX). This can be considered as Overvalued.
Can you provide the profitability details for DOGWOOD THERAPEUTICS INC?
DOGWOOD THERAPEUTICS INC (DWTX) has a profitability rating of 1 / 10.
What is the financial health of DOGWOOD THERAPEUTICS INC (DWTX) stock?
The financial health rating of DOGWOOD THERAPEUTICS INC (DWTX) is 7 / 10.